MyFinsight
Home
Blog
About
Net change in cash
and cash...
-$5,931K
(69.95%↑ Y/Y)
Foreign exchange loss
(gain)
-$1,412K
(-141.96%↓ Y/Y)
Depreciation
$302K
(-65.72%↓ Y/Y)
Accounts payable
$246K
(130.94%↑ Y/Y)
Accrued expenses
$212K
(195.50%↑ Y/Y)
Share-based compensation
expense
$172K
(-94.99%↓ Y/Y)
Accrued interest
receivable
-$25K
(88.64%↑ Y/Y)
Net cash used in
operating activities
-$4,515K
(64.47%↑ Y/Y)
Effect of foreign
exchange rate on cash and...
-$1,412K
(-141.96%↓ Y/Y)
Net cash provided by
(used in) investing...
-$4K
(97.24%↑ Y/Y)
Canceled cashflow
$2,369K
Net loss
-$6,728K
(46.77%↑ Y/Y)
Permit refund of
construction in progress
-$4K
Income tax payable
-$90K
(-257.89%↓ Y/Y)
Prepaid expenses and
other current assets
$52K
(-81.49%↓ Y/Y)
Income tax receivable
$14K
Back
Back
Cash Flow
XBiotech Inc. (XBIT)
XBiotech Inc. (XBIT)
source: myfinsight.com